InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Cover Story

  • IP under threat from competition clampdown

    From pharmaceuticals to telecoms, software and even copyright licensing, antitrust authorities are clamping down on abuses of IP rights. James Nurton, Eileen McDermott and Peter Ollier examine why IP is under scrutiny and discuss some pending cases and investigations

Features

Survey

  • Copyright survey results

    Top copyright firms ranked in 19 jurisdictions. Plus: Eileen McDermott explores some areas in which the internet has highlighted a need for change in copyright law

IP Clinic

  • Should we embrace viral marketing?

    My company is about to launch an advertising campaign, and we think it could become very popular. Should we welcome this and are there are any particular trade mark/branding concerns we should be aware of?

Diary

  • Utynam's Heirs

    A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world’s first recorded patent in 1449

Country Updates

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: SCOTUS TC Heartland v Kraft Foods Group Brands oral argument transcript is up! https://t.co/v29vEKCILp

Mar 27 2017 07:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

Likely to be an important question for some applicants, with UPC due to come into force in December this year https://t.co/ASuSYUpRqd

Mar 27 2017 04:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

Don't forget to sign up for our next webinar, on IP in Asia, this Thursday at 3pm (London) https://t.co/gh3Ka8t9q1 @inoviaIP @Minesoftnews

Mar 27 2017 04:38 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements